Irhythm Technologies Inc (NASDAQ:IRTC) Director Vijay K. Lathi sold 150,000 shares of the stock in a transaction that occurred on Thursday, December 7th. The shares were sold at an average price of $52.57, for a total transaction of $7,885,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Vijay K. Lathi also recently made the following trade(s):

  • On Tuesday, December 5th, Vijay K. Lathi sold 57,430 shares of Irhythm Technologies stock. The shares were sold at an average price of $52.41, for a total transaction of $3,009,906.30.

Shares of Irhythm Technologies Inc (IRTC) traded up $0.80 during midday trading on Thursday, reaching $52.76. 272,352 shares of the company’s stock traded hands, compared to its average volume of 262,968. The company has a quick ratio of 7.57, a current ratio of 7.65 and a debt-to-equity ratio of 0.38. Irhythm Technologies Inc has a 1 year low of $24.25 and a 1 year high of $57.90.

Irhythm Technologies (NASDAQ:IRTC) last announced its quarterly earnings results on Wednesday, November 1st. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.34) by $0.05. Irhythm Technologies had a negative net margin of 27.56% and a negative return on equity of 27.67%. The firm had revenue of $25.04 million during the quarter, compared to analysts’ expectations of $24.30 million. During the same period in the prior year, the company posted ($2.80) EPS. The company’s revenue was up 49.2% on a year-over-year basis. research analysts expect that Irhythm Technologies Inc will post -1.17 earnings per share for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Advisor Group Inc. increased its position in Irhythm Technologies by 763.9% in the 3rd quarter. Advisor Group Inc. now owns 2,920 shares of the company’s stock valued at $151,000 after acquiring an additional 2,582 shares during the period. Legal & General Group Plc increased its position in Irhythm Technologies by 131.0% in the 2nd quarter. Legal & General Group Plc now owns 3,373 shares of the company’s stock valued at $143,000 after acquiring an additional 1,913 shares during the period. First Mercantile Trust Co. acquired a new position in Irhythm Technologies in the 2nd quarter valued at approximately $221,000. Voya Investment Management LLC acquired a new position in Irhythm Technologies in the 2nd quarter valued at approximately $274,000. Finally, GSA Capital Partners LLP acquired a new position in Irhythm Technologies in the 2nd quarter valued at approximately $289,000. Hedge funds and other institutional investors own 97.80% of the company’s stock.

Several equities analysts recently commented on IRTC shares. Canaccord Genuity increased their price objective on shares of Irhythm Technologies from $49.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, September 22nd. Morgan Stanley increased their price objective on shares of Irhythm Technologies from $50.00 to $65.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. Zacks Investment Research downgraded shares of Irhythm Technologies from a “hold” rating to a “sell” rating in a research note on Wednesday, September 6th. Royal Bank Of Canada started coverage on shares of Irhythm Technologies in a research note on Monday. They issued an “outperform” rating and a $79.00 price objective for the company. Finally, ValuEngine raised shares of Irhythm Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, October 21st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $65.25.

TRADEMARK VIOLATION NOTICE: “Irhythm Technologies Inc (IRTC) Director Sells $7,885,500.00 in Stock” was reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2017/12/07/irhythm-technologies-inc-irtc-director-sells-7885500-00-in-stock.html.

Irhythm Technologies Company Profile

iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.

Insider Buying and Selling by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for Irhythm Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.